|
|
|
|
|
Detail |
hsa-miR-1 |
|
Causal |
Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. |
2008 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. |
2007 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. |
2005 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa. |
2007 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Cerebellar neurodegeneration in the absence of microRNAs. |
2007 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. |
2007 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in
xenotransplanted mice by promoting myogenic differentiation. |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
Loss of Cardiac microRNA-Mediated Regulation Leads to Dilated Cardiomyopathy and Heart Failure. |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. |
2008 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
Downregulation of microRNA-1 (miR-1) in lung cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis bymiR-1. |
2008 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Common microRNA signature in mouse models of retinal degeneration. |
2008 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
MicroRNA-regulated pathways associated with endometriosis. |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Causal |
microRNA-1 negatively regulates expression of the hypertrophy-associated genes calmodulin and Mef2a. |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a. |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Alteration of microRNA expression in vinyl-carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol |
2009 |
|
|
|
|
|
|
hsa-miR-1 |
|
Unspecified |
Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1 |
2009 |
|
|
|
|
|
|